DeepTek launches Global Access Pricing with an agreement from Unitaid and CHAI to make its WHO-recommended Chest X-ray AI for TB screening more affordable for public sector and not-for-profit providers in 138 LMICs.

The program aims to accelerate early TB detection, expand equitable access to high-quality diagnostics, and strengthen national TB programmes by reducing financial barriers.

The initiative showcases a collaboration among DeepTek, Unitaid, and CHAI to remove financial barriers to adopting AI in LMICs and broaden access to high-quality TB screening.

For more details, contact [email protected].

The annual subscription covers unlimited AI analyses per connected X-ray unit, plus installation, training, updates, maintenance and support, with online, offline, and hybrid deployment suitable for settings including mobile units and low-connectivity areas.

The subscription model enables online, offline, and hybrid deployment across various facilities, including low-connectivity environments.

Interested healthcare providers and programs can reach out to learn more about Global Access Pricing.

Executive quotes from Ajit Patil, Dr. Amit Kharat, Dr. Philippe Duneton, and Marie Chantale Lepine emphasize affordability, scale, and expanded access to timely diagnosis.

Pricing reductions aim to bring annual costs to roughly one-third of previous levels, enabling programs to screen about three times more people within existing budgets.

Beyond TB, the AI detects 20+ chest abnormalities, enabling broader lung health screening and potentially indicating conditions like cardiomegaly, silicosis, and lung cancer under a transparent pricing model.